Last Updated on June 22, 2023

Advances in Alzheimer's Disease- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: IOS Press BV

Abbreviation: Adv. Alzheimer's Dis.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.05

SJR

 0.108

h-Index

 10

Rank

 25520

Important Details

Title Advances in Alzheimer's Disease
Standard Abbreviation Adv. Alzheimer's Dis.
Type of Publication Book series
Discipline Neurology (clinical) (Q4)
Impact Score 0.05
SCImago Journal Rank (SJR) 0.108
h-index 10
Overall Rank 25520
Publisher Name IOS Press BV
Publication Country Netherlands
International Standard Serial Number (ISSN) 22105735, 22105727
Coverage and History 2011-2012, 2015, 2017, 2020-2022
Best Quartile Q4
Total Citations Received
(Last 3 Year)
4

About Advances in Alzheimer's Disease


Advances in Alzheimer's Disease is a book series published by IOS Press BV. This book series covers the area[s] related to Neurology (clinical), etc. The coverage history of this book series is as follows: 2011-2012, 2015, 2017, 2020-2022. The rank of this book series is 25520. This book series's impact score, h-index, and SJR are 0.05, 10, and 0.108, respectively. The ISSN of this book series is/are as follows: 22105735, 22105727.

The best quartile of Advances in Alzheimer's Disease is Q4. This book series has received a total of 4 citations during the last three years (Preceding 2022).


Advances in Alzheimer's Disease Impact Score 2022-2023


The latest impact score (IS) of the Advances in Alzheimer's Disease is 0.05. It is computed in the year 2023 as per its definition and based on Scopus data.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact Score Graph


Check below the Impact Score trends of Advances in Alzheimer's Disease. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.05
2021 0.01
2020 0.00
2019 0.06
2018 0.10
2017 0.06
2016 0.00
2015 0.00
2014 0.47

Advances in Alzheimer's Disease h-index


  Table Setting

The h-index of Advances in Alzheimer's Disease is 10. By definition of the h-index, this book series has at least 10 published articles with more than 10 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Advances in Alzheimer's Disease ISSN


The International Standard Serial Number (ISSN) of Advances in Alzheimer's Disease is/are as follows: 22105735, 22105727.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Advances in Alzheimer's Disease Ranking and SCImago Journal Rank (SJR)


The Advances in Alzheimer's Disease is ranked 25520 among 27955 Journals, Conferences, and Book Series. As per SJR, this book series is ranked 0.108.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Advances in Alzheimer's Disease Publisher


Table Setting

The publisher of Advances in Alzheimer's Disease is IOS Press BV. The publishing house of this book series is located in the Netherlands. Its coverage history is as follows: 2011-2012, 2015, 2017, 2020-2022.


Call For Papers (CFPs)


Please check the official website of this book series to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Advances in Alzheimer's Disease is Adv. Alzheimer's Dis.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Adv. Alzheimer's Dis.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Advances in Alzheimer's Disease


If your area of research or discipline is related to Neurology (clinical), etc., please check the book series's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Advances in Alzheimer's Disease?

The latest impact score of Advances in Alzheimer's Disease is 0.05. It is computed in the year 2023.


What is the h-index of Advances in Alzheimer's Disease?

The latest h-index of Advances in Alzheimer's Disease is 10. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Advances in Alzheimer's Disease?

The latest SCImago Journal Rank (SJR) of Advances in Alzheimer's Disease is 0.108. It is calculated in the year 2023.


What is the ranking of Advances in Alzheimer's Disease?

The latest ranking of Advances in Alzheimer's Disease is 25520. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Advances in Alzheimer's Disease?

Advances in Alzheimer's Disease is published by IOS Press BV. The publication country of this book series is Netherlands.


What is the abbreviation of Advances in Alzheimer's Disease?

This standard abbreviation of Advances in Alzheimer's Disease is Adv. Alzheimer's Dis..


Is "Advances in Alzheimer's Disease" a Journal, Conference or Book Series?

Advances in Alzheimer's Disease is a book series published by IOS Press BV.


What is the scope of Advances in Alzheimer's Disease?

The scope of Advances in Alzheimer's Disease is as follows:

  • Neurology (clinical)

For detailed scope of Advances in Alzheimer's Disease, check the official website of this book series.


What is the ISSN of Advances in Alzheimer's Disease?

The International Standard Serial Number (ISSN) of Advances in Alzheimer's Disease is/are as follows: 22105735, 22105727.


What is the best quartile for Advances in Alzheimer's Disease?

The best quartile for Advances in Alzheimer's Disease is Q4.


What is the coverage history of Advances in Alzheimer's Disease?

The coverage history of Advances in Alzheimer's Disease is as follows 2011-2012, 2015, 2017, 2020-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Dermatologia Kliniczna Journal Cornetis 25442 7 0.00
Zeitschrift fur Germanistische Linguistik Journal De Gruyter Mouton 22945 15 0.19
European Union Politics Journal SAGE Publications Ltd 2250 72 2.64
Journal of Competition Law and Economics Journal Oxford University Press 14815 29 0.72
Air and Space Power Journal (discontinued) Journal AU Press 28397 9 0.20
Materials Research Journal Universidade Federal de Sao Carlos 14791 65 1.62
Journal of Sociology Journal SAGE Publications Ltd 6009 58 3.21
European Journal of Cancer, Supplement Journal Elsevier Ltd. 9063 28 1.93
Revista do Colegio Brasileiro de Cirurgioes Journal Colegio Brasileiro de Cirurgioes 16407 26 0.82
Epites-Epiteszettudomany Journal Akademiai Kiado 23580 4 0.06

Check complete list




Advances in Alzheimer's Disease Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.05
2021 0.01
2020 0.00
2019 0.06
2018 0.10
2017 0.06
2016 0.00
2015 0.00
2014 0.47



Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Stroke
American Heart Association | United States

European Stroke Journal
SAGE Publications Inc. | United States

Annual Review of Vision Science
Annual Reviews Inc. | United States

See All